Somatic comorbidity in Polish patients with epilepsy

Area of Science:

• Neurology
• Internal Medicine
• Clinical Pharmacy

Background:

• Epilepsy is associated with a high burden of somatic and psychiatric disorders.
• Comorbidities in epilepsy patients can complicate management and impact quality of life.

Purpose of the Study:

• To determine the prevalence and risk factors of somatic comorbidities in adult epilepsy patients.
• To analyze the use of concomitant medications for somatic disorders in this population.

Main Methods:

• A study involving 636 adult epilepsy patients treated at a university epilepsy clinic.
• Data collection via structured interviews and medical records, including epilepsy details, antiepileptic drugs (AEDs), and somatic comorbidities.
• Logistic regression analysis to identify independent risk factors for somatic comorbidities.

Main Results:

• 34% of patients had at least one somatic comorbidity, most commonly cardiovascular diseases, allergies, and migraine.
• 31.4% of patients were prescribed medication for somatic disorders.
• Independent risk factors for comorbidities included older age, shorter epilepsy duration, lower seizure frequency, and fewer AEDs.

Conclusions:

• Somatic comorbidities and non-AED comedication are prevalent in one-third of young adult epilepsy patients.
• Patients with pharmacoresistant epilepsy may be at risk for underdiagnosed and undertreated somatic conditions.
• The presence of comorbidities necessitates careful consideration in the diagnosis and treatment of both epilepsy and coexisting conditions.